[1]
2021. Transient liver enzyme derangement following Remdesivir use: a case series. Journal of Pharmacovigilance and Drug Research. 2, 3 (Sep. 2021), 30–34. DOI:https://doi.org/10.53411/jpadr.2021.2.3.7.